SB1810 EngrossedLRB099 00139 KTG 20139 b



1 AN ACT concerning State government.


2 Be it enacted by the People of the State of Illinois,

3represented in the General Assembly:



4 Section 5. The Alcoholism and Other Drug Abuse and 
5Dependency Act is amended by changing Section 5-23 as follows:

6 (20 ILCS 301/5-23)
7 Sec. 5-23. Drug Overdose Prevention Program.
8 (a) Reports of drug overdose.
9  (1) The Director of the Division of Alcoholism and 
10 Substance Abuse may publish annually a report on drug 
11 overdose trends statewide that reviews State death rates 
12 from available data to ascertain changes in the causes or 
13 rates of fatal and nonfatal drug overdose for the preceding 
14 period of not less than 5 years. The report shall also 
15 provide information on interventions that would be 
16 effective in reducing the rate of fatal or nonfatal drug 
17 overdose.
18  (2) The report may include:
19   (A) Trends in drug overdose death rates.
20   (B) Trends in emergency room utilization related 
21 to drug overdose and the cost impact of emergency room 
22 utilization.
23   (C) Trends in utilization of pre-hospital and 
 
 
SB1810 Engrossed- 2 -LRB099 00139 KTG 20139 b


1 emergency services and the cost impact of emergency 
2 services utilization.
3   (D) Suggested improvements in data collection.
4   (E) A description of other interventions effective 
5 in reducing the rate of fatal or nonfatal drug 
6 overdose.
7 (b) Programs; drug overdose prevention.
8  (1) The Director may establish a program to provide for 
9 the production and publication, in electronic and other 
10 formats, of drug overdose prevention, recognition, and 
11 response literature. The Director may develop and 
12 disseminate curricula for use by professionals, 
13 organizations, individuals, or committees interested in 
14 the prevention of fatal and nonfatal drug overdose, 
15 including, but not limited to, drug users, jail and prison 
16 personnel, jail and prison inmates, drug treatment 
17 professionals, emergency medical personnel, hospital 
18 staff, families and associates of drug users, peace 
19 officers, firefighters, public safety officers, needle 
20 exchange program staff, and other persons. In addition to 
21 information regarding drug overdose prevention, 
22 recognition, and response, literature produced by the 
23 Department shall stress that drug use remains illegal and 
24 highly dangerous and that complete abstinence from illegal 
25 drug use is the healthiest choice. The literature shall 
26 provide information and resources for substance abuse 
 
 
SB1810 Engrossed- 3 -LRB099 00139 KTG 20139 b


1 treatment.
2  The Director may establish or authorize programs for 
3 prescribing, dispensing, or distributing naloxone 
4 hydrochloride or any other similarly acting and equally 
5 safe drug approved by the U.S. Food and Drug Administration 
6 for the treatment of drug overdose. Such programs may 
7 include the prescribing of naloxone hydrochloride or any 
8 other similarly acting and equally safe drug approved by 
9 the U.S. Food and Drug Administration for the treatment of 
10 drug overdose to and education about administration by 
11 individuals who are not personally at risk of opioid 
12 overdose.
13  (2) The Director may provide advice to State and local 
14 officials on the growing drug overdose crisis, including 
15 the prevalence of drug overdose incidents, trends in drug 
16 overdose incidents, and solutions to the drug overdose 
17 crisis.
18 (c) Grants.
19  (1) The Director may award grants, in accordance with 
20 this subsection, to create or support local drug overdose 
21 prevention, recognition, and response projects. Local 
22 health departments, correctional institutions, hospitals, 
23 universities, community-based organizations, and 
24 faith-based organizations may apply to the Department for a 
25 grant under this subsection at the time and in the manner 
26 the Director prescribes.
 
 
SB1810 Engrossed- 4 -LRB099 00139 KTG 20139 b


1  (2) In awarding grants, the Director shall consider the 
2 necessity for overdose prevention projects in various 
3 settings and shall encourage all grant applicants to 
4 develop interventions that will be effective and viable in 
5 their local areas.
6  (3) The Director shall give preference for grants to 
7 proposals that, in addition to providing life-saving 
8 interventions and responses, provide information to drug 
9 users on how to access drug treatment or other strategies 
10 for abstaining from illegal drugs. The Director shall give 
11 preference to proposals that include one or more of the 
12 following elements:
13   (A) Policies and projects to encourage persons, 
14 including drug users, to call 911 when they witness a 
15 potentially fatal drug overdose.
16   (B) Drug overdose prevention, recognition, and 
17 response education projects in drug treatment centers, 
18 outreach programs, and other organizations that work 
19 with, or have access to, drug users and their families 
20 and communities.
21   (C) Drug overdose recognition and response 
22 training, including rescue breathing, in drug 
23 treatment centers and for other organizations that 
24 work with, or have access to, drug users and their 
25 families and communities.
26   (D) The production and distribution of targeted or 
 
 
SB1810 Engrossed- 5 -LRB099 00139 KTG 20139 b


1 mass media materials on drug overdose prevention and 
2 response.
3   (E) Prescription and distribution of naloxone 
4 hydrochloride or any other similarly acting and 
5 equally safe drug approved by the U.S. Food and Drug 
6 Administration for the treatment of drug overdose.
7   (F) The institution of education and training 
8 projects on drug overdose response and treatment for 
9 emergency services and law enforcement personnel.
10   (G) A system of parent, family, and survivor 
11 education and mutual support groups.
12  (4) In addition to moneys appropriated by the General 
13 Assembly, the Director may seek grants from private 
14 foundations, the federal government, and other sources to 
15 fund the grants under this Section and to fund an 
16 evaluation of the programs supported by the grants.
17 (d) Health care professional prescription of drug overdose 
18treatment medication. 
19  (1) A health care professional who, acting in good 
20 faith, directly or by standing order, prescribes or 
21 dispenses an opioid antidote to a patient who, in the 
22 judgment of the health care professional, is capable of 
23 administering the drug in an emergency, shall not, as a 
24 result of his or her acts or omissions, be subject to 
25 disciplinary or other adverse action under the Medical 
26 Practice Act of 1987, the Physician Assistant Practice Act 
 
 
SB1810 Engrossed- 6 -LRB099 00139 KTG 20139 b


1 of 1987, the Nurse Practice Act, the Pharmacy Practice Act, 
2 or any other professional licensing statute.
3  (2) A person who is not otherwise licensed to 
4 administer an opioid antidote may in an emergency 
5 administer without fee an opioid antidote if the person has 
6 received the patient information specified in paragraph 
7 (4) of this subsection and believes in good faith that 
8 another person is experiencing a drug overdose. The person 
9 shall not, as a result of his or her acts or omissions, 
10 except for willful and wanton misconduct, be liable for 
11 civil damages, and shall not, as a result of his or her 
12 acts or omissions, be liable for any violation of the 
13 Medical Practice Act of 1987, the Physician Assistant 
14 Practice Act of 1987, the Nurse Practice Act, the Pharmacy 
15 Practice Act, or any other professional licensing statute, 
16 or subject to any criminal prosecution arising from or 
17 related to the unauthorized practice of medicine or the 
18 possession of an opioid antidote.
19  (3) A health care professional prescribing an opioid 
20 antidote to a patient shall ensure that the patient 
21 receives the patient information specified in paragraph 
22 (4) of this subsection. Patient information may be provided 
23 by the health care professional or a community-based 
24 organization, substance abuse program, or other 
25 organization with which the health care professional 
26 establishes a written agreement that includes a 
 
 
SB1810 Engrossed- 7 -LRB099 00139 KTG 20139 b


1 description of how the organization will provide patient 
2 information, how employees or volunteers providing 
3 information will be trained, and standards for documenting 
4 the provision of patient information to patients. 
5 Provision of patient information shall be documented in the 
6 patient's medical record or through similar means as 
7 determined by agreement between the health care 
8 professional and the organization. The Director of the 
9 Division of Alcoholism and Substance Abuse, in 
10 consultation with statewide organizations representing 
11 physicians, advanced practice nurses, physician 
12 assistants, substance abuse programs, and other interested 
13 groups, shall develop and disseminate to health care 
14 professionals, community-based organizations, substance 
15 abuse programs, and other organizations training materials 
16 in video, electronic, or other formats to facilitate the 
17 provision of such patient information. 
18  (4) For the purposes of this subsection:
19  "Opioid antidote" means naloxone hydrochloride or any 
20 other similarly acting and equally safe drug approved by 
21 the U.S. Food and Drug Administration for the treatment of 
22 drug overdose.
23  "Health care professional" means a physician licensed 
24 to practice medicine in all its branches, a physician 
25 assistant who has been delegated the prescription or 
26 dispensation of an opioid antidote by his or her 
 
 
SB1810 Engrossed- 8 -LRB099 00139 KTG 20139 b


1 supervising physician, an advanced practice registered 
2 nurse who has a written collaborative agreement with a 
3 collaborating physician that authorizes the prescription 
4 or dispensation of an opioid antidote, or an advanced 
5 practice nurse who practices in a hospital or ambulatory 
6 surgical treatment center and possesses appropriate 
7 clinical privileges in accordance with the Nurse Practice 
8 Act. 
9  "Patient" includes a person who is not at risk of 
10 opioid overdose but who, in the judgment of the physician, 
11 may be in a position to assist another individual during an 
12 overdose and who has received patient information as 
13 required in paragraph (2) of this subsection on the 
14 indications for and administration of an opioid antidote.
15  "Patient information" includes information provided to 
16 the patient on drug overdose prevention and recognition; 
17 how to perform rescue breathing and resuscitation; opioid 
18 antidote dosage and administration; the importance of 
19 calling 911; care for the overdose victim after 
20 administration of the overdose antidote; and other issues 
21 as necessary. 

22(Source: P.A. 96-361, eff. 1-1-10.)


23 Section 99. Effective date. This Act takes effect upon 
24becoming law.